New York Society for the Relief of Ruptured & Crippled Maintaining

New York Society for the Relief of Ruptured & Crippled Maintaining was paid $20.41M by Medicaid between Jan 2018 and Dec 2024, across 142 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 31% of everything it billed.

Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#61 of 231

Median peer was paid$561K

This provider vs. median36×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	4,501	$340K
2019	21,280	$1.60M
2020	39,285	$2.99M
2021	53,467	$3.81M
2022	49,603	$3.84M
2023	53,034	$4.23M
2024incomplete	43,407	$3.60M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	31%	32,902	29,575	$6.36M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	21%	34,356	12,148	$4.32M
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	13%	14,703	14,195	$2.68M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	3.9%	4,098	1,242	$796K
97162		3.3%	3,320	3,294	$667K
20610		3.2%	2,008	1,940	$648K
97530	Therapeutic activities, direct patient contact, each 15 minutes	3.1%	5,709	2,161	$637K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	2.9%	1,647	1,556	$594K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.9%	1,791	1,462	$384K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	1.4%	1,054	1,045	$284K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	1.4%	1,653	1,623	$276K
20611		1.3%	446	434	$267K

130 more codes

97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	1.2%	8,520	$255K
96415		1.2%	418	$253K
97161		1.2%	2,097	$243K
80053	Comprehensive metabolic panel	1.1%	10,553	$219K
73700		<1%	944	$193K
J0490	Injection, belimumab, 10 mg	<1%	114	$155K
29125		<1%	610	$134K
73221		<1%	337	$123K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	3,874	$96K
99213	Doctor's office visit, returning patient (routine)	<1%	406	$80K
97116		<1%	1,551	$61K
72141		<1%	202	$58K
86480		<1%	942	$57K
86885		<1%	1,560	$52K
86901		<1%	2,387	$48K
97535	Self-care/home management training, each 15 minutes	<1%	698	$47K
86900		<1%	2,381	$39K
36415	Collection of venous blood by venipuncture	<1%	14,305	$39K
97166		<1%	181	$33K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	1,555	$32K
80048	Basic metabolic panel (calcium, ionized)	<1%	1,273	$25K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	610	$18K
77077		<1%	2,561	$17K
73562		<1%	4,505	$15K
J3262	Injection, tocilizumab, 1 mg	<1%	28	$15K
29130		<1%	72	$14K
72082		<1%	2,755	$12K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	262	$10K
0001A		<1%	415	$10K
0002A		<1%	390	$9K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	490	$8K
90686		<1%	461	$8K
73564		<1%	1,071	$8K
86769		<1%	473	$8K
73630		<1%	2,731	$7K
64483		<1%	12	$6K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	316	$6K
73522		<1%	1,440	$5K
73590		<1%	473	$4K
73502		<1%	1,587	$4K
73560		<1%	565	$4K
85610		<1%	2,424	$4K
73610		<1%	1,080	$4K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	10,832	$3K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	2,023	$3K
72100		<1%	1,067	$3K
71046	Radiologic examination, chest; 2 views	<1%	1,242	$3K
86160		<1%	4,768	$3K
73600		<1%	1,038	$3K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	695	$2K
86140		<1%	7,754	$2K
85652		<1%	8,256	$2K
73552		<1%	234	$2K
73030		<1%	1,238	$2K
97803		<1%	63	$2K
72170		<1%	1,044	$2K
73110		<1%	276	$2K
90682		<1%	61	$2K
80061	Lipid panel	<1%	127	$1K
96375	Therapeutic injection; each additional sequential IV push	<1%	206	$1K
73130		<1%	1,388	$1K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,560	$1K
81001		<1%	3,557	$1K
77072		<1%	175	$982.63
85730		<1%	1,438	$977.79
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	432	$950.91
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	530	$865.18
81025		<1%	289	$849.35
86225		<1%	2,729	$757.55
72050		<1%	276	$737.60
82570		<1%	2,898	$636.43
82550		<1%	1,284	$631.23
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	1,958	$610.90
86803		<1%	685	$591.58
82728		<1%	500	$545.75
86147		<1%	109	$501.12
90656		<1%	44	$450.14
84156		<1%	2,823	$439.45
J2704	Injection, propofol, 10 mg	<1%	1,283	$398.89
90661		<1%	15	$378.05
86704		<1%	535	$370.06
87340		<1%	589	$359.92
84443	Thyroid stimulating hormone (TSH)	<1%	613	$328.53
86235		<1%	610	$323.16
82784		<1%	102	$316.23
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	1,160	$315.48
88300		<1%	14	$242.00
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,247	$239.16
87070		<1%	88	$211.25
J7120	Ringers lactate infusion, up to 1000 cc	<1%	941	$158.77
86200		<1%	250	$154.64
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	17	$147.34
83615		<1%	466	$140.46
82085		<1%	494	$134.37
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	1,086	$123.72
J0670	Injection, mepivacaine hydrochloride, per 10 ml	<1%	315	$114.14
85378		<1%	44	$98.56
86038		<1%	524	$95.69
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	440	$93.94
84439		<1%	122	$93.72
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	897	$91.27
84484		<1%	44	$87.00
73070		<1%	74	$74.35
86431		<1%	344	$70.37
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	1,325	$69.24
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	1,443	$54.83
86146		<1%	99	$46.92
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,039	$43.87
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	46	$34.68
73120		<1%	37	$31.38
85027		<1%	129	$27.49
72040		<1%	13	$27.26
83874		<1%	44	$23.30
77080		<1%	13	$20.80
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	333	$17.65
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	52	$16.32
85613		<1%	81	$15.64
85007		<1%	97	$7.72
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	20	$5.12
83550		<1%	69	$1.00
83540		<1%	70	$1.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	96	$0.00
88311		0%	12	$0.00
82607		0%	12	$0.00
J1170	Injection, hydromorphone, up to 4 mg	0%	14	$0.00
77091		0%	28	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	57	$0.00
73140		0%	16	$0.00
99080		0%	185	$0.00
83516		0%	18	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSHAPIRO, LOUIS (PRESIDENT AND CEO)